Tadeusz Robak

89PUBLICATIONS
204CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Microbial geneticsRespiratory diseasesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (89)

|Oct 23, 2026
PROTAC degraders for lymphoid malignancies - current status and future directions.

|Oct 02, 2026
First-line ibrutinib-venetoclax in chronic lymphocytic leukemia: GLOW 67-month results and grade 3/4 adverse event-free progression-free survival.

|Sep 07, 2026
Predicted microbiome-associated metabolic pathways are linked to immune checkpoint modulation in chronic lymphocytic leukaemia.

|Aug 27, 2026
BTK Inhibitors for the Treatment of Mantle Cell Lymphoma-Current Status and Perspectives.

|Aug 10, 2026
Efficacy and tolerability of venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukemia - real-world analysis of Polish adult leukemia study group.

|Jun 15, 2026
The preclinical discovery and development of acalabrutinib for the treatment of mantle cell lymphoma.

Pageof 15

Frequent Collaborators

18 joint publications

Paweł Robak

10 joint publications

Damian Mikulski

7 joint publications

Anna Wolska-Washer

7 joint publications

Anna Puła